Search

Tate & Lyle PLC

Aperta

SettoreConsumatore difensivo

372.2 1.09

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

369

Massimo

373.2

Metriche Chiave

By Trading Economics

Entrata

78M

56M

Vendite

63M

1B

P/E

Media del settore

52.286

28.085

EPS

0.2

Rendimento da dividendi

5.45

Margine di Profitto

5.469

Dipendenti

5,000

EBITDA

95M

188M

Raccomandazioni

By TipRanks

Raccomandazioni

Neutrale

Previsioni per 12 mesi

+15.38% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

5.45%

3.68%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-5.3M

1.6B

Apertura precedente

371.11

Chiusura precedente

372.2

Notizie sul Sentiment di mercato

By Acuity

50%

50%

70 / 147 Classifica in Consumer defensive

Tate & Lyle PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 gen 2026, 23:54 UTC

Discorsi di Mercato

CBA Could Underperform Again in 2026 -- Market Talk

12 gen 2026, 23:48 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

12 gen 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen -- Market Talk

12 gen 2026, 23:43 UTC

Discorsi di Mercato

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 gen 2026, 23:18 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 gen 2026, 21:56 UTC

Discorsi di Mercato

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 gen 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

12 gen 2026, 21:50 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

12 gen 2026, 21:18 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

12 gen 2026, 21:18 UTC

Discorsi di Mercato

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 gen 2026, 20:54 UTC

Utili

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 gen 2026, 20:48 UTC

Discorsi di Mercato

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 gen 2026, 20:33 UTC

Discorsi di Mercato

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 gen 2026, 20:18 UTC

Acquisizioni, Fusioni, Takeovers

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 gen 2026, 20:18 UTC

Acquisizioni, Fusioni, Takeovers

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 gen 2026, 19:39 UTC

Discorsi di Mercato

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 gen 2026, 19:36 UTC

Discorsi di Mercato

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 gen 2026, 19:36 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

12 gen 2026, 19:33 UTC

Discorsi di Mercato

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 gen 2026, 19:24 UTC

Acquisizioni, Fusioni, Takeovers

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 gen 2026, 19:22 UTC

Acquisizioni, Fusioni, Takeovers

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 gen 2026, 18:21 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 gen 2026, 18:20 UTC

Acquisizioni, Fusioni, Takeovers

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 gen 2026, 18:19 UTC

Discorsi di Mercato

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 gen 2026, 18:16 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 gen 2026, 18:09 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

12 gen 2026, 18:09 UTC

Discorsi di Mercato

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 gen 2026, 18:01 UTC

Acquisizioni, Fusioni, Takeovers

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 gen 2026, 18:00 UTC

Discorsi di Mercato

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Tate & Lyle PLC Previsione

Obiettivo di Prezzo

By TipRanks

15.38% in crescita

Previsioni per 12 mesi

Media 425.52 GBX  15.38%

Alto 500 GBX

Basso 367.6 GBX

Basato su 5 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Tate & Lyle PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Neutrale

5 ratings

1

Acquista

4

Mantieni

0

Vendi

Sentiment

By Acuity

70 / 147 Classifica in Consumatore difensivo

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Tate & Lyle PLC

Tate & Lyle plc, together with its subsidiaries, engages in the provision of ingredients and solutions to the food, beverage, and other industries in North America, Asia, Middle East, Africa, Latin America, and Europe. The company operates through three segments: Food & Beverage Solutions, Sucralose, Primary Products Europe, and Primient. It offers dairy products, soups, sauces, and dressings; bakery products and snacks; texturants; sweeteners, such as high fructose corn syrup and dextrose; industrial starches; acidulants; and corn gluten feed and meal and corn oil. The company was incorporated in 1903 and is headquartered in London, the United Kingdom.
help-icon Live chat